
Venus Medtech (Hangzhou) Inc.
HKEX:2500.HK
3.7 (HKD) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 298.036 | 774.396 | 1,879.431 | 2,955.212 | 2,708.17 | 2,413.254 | 164.914 | 59.015 |
Short Term Investments
| 7.666 | 7.24 | 0 | -4.313 | 44.128 | 0 | 0 | 13.068 |
Cash and Short Term Investments
| 305.702 | 781.636 | 1,879.431 | 2,955.212 | 2,752.298 | 2,413.254 | 164.914 | 72.083 |
Net Receivables
| 331.115 | 290.607 | 303.388 | 302.096 | 231.031 | 162.2 | 80.646 | 17.87 |
Inventory
| 98.061 | 112.942 | 104.396 | 90.519 | 59.904 | 24.789 | 16.685 | 9.418 |
Other Current Assets
| 67.602 | 422.882 | 181.755 | 91.795 | 361.328 | 304.208 | 28.393 | 35.381 |
Total Current Assets
| 802.48 | 1,608.067 | 2,468.97 | 3,439.622 | 3,360.433 | 2,904.451 | 290.638 | 121.684 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 523.899 | 693.468 | 472.023 | 261.546 | 109.611 | 61.115 | 48.081 | 19.896 |
Goodwill
| 1,039.641 | 1,024.354 | 1,238.535 | 519.711 | 487.317 | 479.626 | 471.857 | 0 |
Intangible Assets
| 443.447 | 551.022 | 612.304 | 306.595 | 248.371 | 189.904 | 191.12 | 23.726 |
Goodwill and Intangible Assets
| 1,483.088 | 1,575.376 | 1,850.839 | 826.306 | 735.688 | 669.53 | 662.977 | 23.726 |
Long Term Investments
| 406.925 | 509.996 | 477.08 | 573.846 | 64.865 | 29.74 | 0 | 15.029 |
Tax Assets
| 24.471 | 0 | 9.941 | 8.17 | 1.156 | 2.8 | 2.711 | 0 |
Other Non-Current Assets
| 8.907 | 26.807 | 3.982 | -0.033 | 46.474 | 1.172 | 29.974 | 13.676 |
Total Non-Current Assets
| 2,447.29 | 2,805.647 | 2,813.865 | 1,669.835 | 957.794 | 764.357 | 743.743 | 72.327 |
Total Assets
| 3,249.77 | 4,413.714 | 5,282.835 | 5,109.457 | 4,318.227 | 3,668.808 | 1,034.381 | 194.011 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 30.229 | 33.855 | 9.126 | 8.751 | 5.295 | 1.452 | 0.983 | 2.94 |
Short Term Debt
| 56.109 | 494.7 | 246.06 | 22.627 | -363.883 | 128.992 | 85.959 | 32.164 |
Tax Payables
| 0.058 | 2.157 | 5.006 | 0.48 | 0 | 1.939 | 5.859 | 1.849 |
Deferred Revenue
| 0 | 0 | 0 | 163.05 | 374.975 | 425.652 | 403.708 | 60.715 |
Other Current Liabilities
| 275.353 | 274.456 | 231.912 | 13.626 | 14.155 | 436.075 | 403.329 | 59.014 |
Total Current Liabilities
| 361.749 | 805.168 | 492.104 | 208.534 | 405.517 | 568.458 | 496.13 | 95.967 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 312.98 | 331.486 | 653.583 | 48.148 | 21.671 | 17.312 | 15.355 | 3.923 |
Deferred Revenue Non-Current
| 0 | 0 | 0.6 | 0 | 1.062 | -37.292 | 13.796 | 12.923 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 17.411 | 53.451 | 32.942 | 37.292 | 38.726 | -11.94 |
Other Non-Current Liabilities
| 363.942 | 357.714 | 505.837 | 220.931 | 0 | 0 | 0 | 12.923 |
Total Non-Current Liabilities
| 676.922 | 689.2 | 1,159.42 | 269.079 | 55.675 | 54.604 | 67.877 | 16.846 |
Total Liabilities
| 1,038.671 | 1,494.368 | 1,651.524 | 477.613 | 461.192 | 623.062 | 564.007 | 112.813 |
Equity: | ||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 441.012 | 441.012 | 441.012 | 441.012 | 422.969 | 404.469 | 300 | 0 |
Retained Earnings
| -3,596.119 | -2,881.812 | -2,178.058 | -1,120.359 | -746.723 | -564.734 | 0 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 305.182 | 185.249 | 200.191 | 274.061 | -12.519 | -7.897 |
Other Total Stockholders Equity
| 5,366.206 | 5,361.448 | 5,039.728 | 5,039.728 | 3,938.987 | 2,923.182 | 199.672 | 34.8 |
Total Shareholders Equity
| 2,211.099 | 2,920.648 | 3,607.864 | 4,545.63 | 3,815.424 | 3,036.978 | 461.564 | 72.291 |
Total Equity
| 2,211.099 | 2,919.346 | 3,631.311 | 4,631.844 | 3,857.035 | 3,045.746 | 470.374 | 0 |
Total Liabilities & Shareholders Equity
| 3,249.77 | 4,413.714 | 5,282.835 | 5,109.457 | 4,318.227 | 3,668.808 | 1,034.381 | 194.011 |